[3H]MRE 3008F20: A novel antagonist radioligand for the pharmacological and biochemical characterization of human A3 adenosine receptors

Molecular Pharmacology

Volumn 57, Issue 5, 2000, Pages 968-975

  Varani, Katia ^c   Merighi, Stefania ^c   Gessi, Stefania ^c   Klotz, Karl Norbert ^c   Leung, Edward ^a   Baraldi, Pier Giovanni ^c   Cacciari, Barbara ^c   Romagnoli, Romeo ^c   Spalluto, Giampiero ^c   Borea, Pier Andrea ^b  

^a Medco Research Inc   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 FURYL) 5 [3 (4 METHOXYPHENYL)UREIDO] 8 PROPYLPYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5N (3 CHLOROPHENYLCARBAMOYL)AMINO 8 PROPYL 2 (2 FURYL)PYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 5N (4 METHOXYPHENYLCARBAMOYL)AMINO 8 PROPYL 2 (2 FURYL)PYRAZOLO[4,3 E] 1,2,4 TRIAZOLO[1,5 C]PYRIMIDINE; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; 9 CHLORO 2 (2 FURYL) 5,6 DIHYDRO 5 IMINO 1,2,4 TRIAZOLO[2,3 C]QUINAZOLINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE 5' (N METHYLCARBOXAMIDE); ADENOSINE A3 RECEPTOR; ADENOSINE RECEPTOR BLOCKING AGENT; ADENOSINE RECEPTOR STIMULATING AGENT; CYCLIC AMP; IODINE 125; LIGAND; MRE 3010F20; PHENYLISOPROPYLADENOSINE; RECEPTOR SUBTYPE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; ISOTOPE LABELING; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE; ADENYLATE CYCLASE; ANIMALS; BINDING, COMPETITIVE; CHO CELLS; CRICETINAE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PHENYLUREA COMPOUNDS; RADIOLIGAND ASSAY; RATS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P1; TRIAZOLES; TRITIUM;

EID: 17544384891     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. 3 adenosine receptor antagonists: A possible template for adenosine receptor subtypes? J Med Chem 42:4473-4478.
2. 2A adenosine receptors. Life Sci 59:1373-1388.
3. 2A receptor ligands. Biochem Pharmacol 49:461-469.
4. 1 receptor ligands. Eur J Pharmacol 267:55-61.
5. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72:248-254.
6. 3H]-SCH 58261. Br J Pharmacol 121:353-360.
7. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden K, Jacobson KA, Leff P and Williams M (1994) Nomenclature and classification of purinoceptors. Pharmacol Rev 46:143-156.
8. Gilli P, Ferretti V, Gilli G and Borea PA (1994) Enthalpy-entropy compensation in drug-receptor binding. J Phys Chem 98:1515-1518.
9. 3 receptors. J Pharmacol Exp Ther 280:122-128.
10. 3 adenosine receptors: Design of selective ligands and therapeutic prospects Drugs Future 20:689-699.
11. 3 adenosine receptor-selective antagonists. Neuropharmacology 36:1157-1165.
12. 3 receptors: Novel ligands and paradoxical effects. Trends Pharmacol Sci 19:184-191.
13. 3 adenosine receptors: Protective vs. damaging effects identified using novel agonists and antagonists. Drug Dev Res 45:113-124.
14. 3-adenosine receptors. Drug Dev Res 33:51-59.
15. 3 adenosine receptor antagonists. J Med Chem 40:2596-2608.
16. 3 receptor subtypes. J Med Chem 39:4142-4148.
17. Klotz KN, Hessling J, Hegler J, Owman C, Kull B, Fredholm BB and Lohse MJ (1998) Comparative pharmacology of human adenosine receptor subtypes: Characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedebergs Arch Pharmakol 357:1-9.
18. 3 receptor agonists. Biochem Biophys Res Commun 219:904-910.
19. 3 adenosine receptor antagonists. J Med Chem 39:4142-4148.
20. 3 receptor: Sustained cardioprotection. Proc Natl Acad Sci USA 95:6995-6999.
21. 3 receptors: pharmacological properties, species differences and receptor functions. Trends Pharmacol Sci 15:298-306.
22. 2B adenosine receptors. Life Sci 62:1519-1524.
23. 1 adenosine receptors: Persistent activation reveals spare receptors. Mol Pharmacol 30:403-409.
24. Lohse MJ, Lenischow V and Schwabe U (1984) Two affinity states of Ri adenosine receptors in brain membranes. Mol Pharmacol 26:1-9.
25. Munson PJ and Rodbard D (1980) Ligand: A versatile computerized approach for the characterization of ligand binding systems. Anal Biochem 107:220-239.
26. 3 adenosine receptor. Mol Pharmacol 45:978-982.
27. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines Pharmacol Rev 50:413-492.
28. 3 adenosine receptor. Proc Natl Acad Sci USA 90:10365-10369.
29. 3 adenosine receptors. Life Sci 63:81-87.
30. 2A adenosine receptors in human neutrophil membranes. Br J Pharmacol 123:1723-1731.
31. Wilken A, Tawfik-Schlieper H, Klotz KN and Schwabe U (1990) Pharmacological characterization of the adenylate cyclase-coupled adenosine receptor in isolated guinea pig atrial myocytes. Mol Pharmacol 37:916-920.
32. 3 receptor stimulation and cerebral ischemia. Eur J Pharmacol 263:59-67.
33. 3 adenosine receptor. Proc Natl Acad Sci USA 89:7432-7436.